je.st
news
Tag: merck
Merck Animal Health Receives FDA Approval of BRAVECTO (fluralaner topical solution) for Cats and Dogs
2016-07-21 23:00:00| Merck.com - Corporate News
Dateline City: MADISON, N.J. Topical Treatment for Fleas and Ticks Effective for up to 12 Weeks MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced the U.S. Food and Drug Administrations approval of BRAVECTO (fluralaner topical solution) for both cats and dogs, a topical treatment for fleas and ticks effective for up to 12 weeks1,2 following a single dose. Language: English Contact: Merck Animal HealthMedia:Kelly Goss, 913-558-6452 kelly.goss@merck.com orPamela Eisele, 267-305-3558 pamela.eisele@merck.com orInvestor Relations:Amy Klug, 908-740-1898 amy.klug@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
solution
animal
approval
Merck Provides Regulatory Update on Biologics Licensing Application for Investigational Agent Bezlotoxumab
2016-07-21 22:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said that the U.S. Food and Drug Administration (FDA) has requested the submission of new data and analyses from the MODIFY I and MODIFY II clinical trials previously submitted to the pending Biologics Licensing Application (BLA) for bezlotoxumab, an investigational agent for prevention of Clostridium difficile (C. difficile) infection recurrence. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Robert Consalvo, 908-236-1127orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: application
update
agent
regulatory
New Creating Connections educational module now available from Merck
2016-07-15 15:51:55| Beef
“Planning ahead is critical to the effective management of heat stress,” said Grant Crawford, Ph.D., technical services manager, Merck Animal Health. “Feedlots should determi read more
Tags: creating
educational
connections
module
Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Vallée S.A.
2016-07-01 18:05:00| Merck.com - Corporate News
Dateline City: MADISON, N.J. Manufacturer Offers Substantial Portfolio of Animal Vaccines in Latin America MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health (known as MSD Animal Health outside the United States and Canada) today announced it has executed an agreement to acquire a controlling interest in Vallée S.A., a leading privately-held producer of animal health products in Brazil. Language: English Contact: Merck Animal Health Media:Amy Firsching, +1-973-937-5453 amy.firsching@merck.com orPam Eisele, + 1-267-305-3558 pamela.eisele@merck.com orInvestors:Amy Klug, +1-908-740-1898 Amy.klug@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: company
health
sa
interest
Merck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients
2016-06-30 14:30:58| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. and CHARLOTTE, N.C. Companies working alongside providers to develop solutions to serious public health needs KENILWORTH, N.J. and CHARLOTTE, N.C. -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, have agreed to collaborate on the co-development of solutions to help improve population health. Initially, the companies will focus on reducing fracture rates for at-risk osteoporosis patients. Language: English read more
Tags: premier
prevent
patients
collaborate
Sites : [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] next »